Get Started

MNPR

NASD Monopar Therapeutics Inc
Oct 25, 2026 · 7:54 PM ET EOD Market Closed

$70.65 ↑ +0.00 (+0.00%) Trading Up from the previous close of $70.65, $1.19 below the day’s high of $71.84

YTD change
+8.19%
vs 20-day SMA
-8.43%
vs 200-day SMA
-8.32%

Price ranges

Previous day
$69.48 $71.84
open $71.84 close $70.65
-$1.19 (-1.66%)
Today
$69.48 $71.84
$70.65
Past week
$68.81 $75.08
from $71.80 now $70.65
-$1.15 (-1.60%)
Past month
$68.81 $90.00
from $88.84 now $70.65
-$18.19 (-20.48%)
This year
$50.07 $124.82
from $65.30 now $70.65
+$5.35 (+8.19%)

Price & Performance

+16.63 (+30.78%) / 6M

$44.22$72.73$101.23$129.74Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 70.6% away from all-time highs of $240.00
  • MNPR is up 8% since the beginning of the year
  • MNPR is down 13% over the past 12 months
  • MNPR is down 20% over the past 1 month
  • 18% of all MNPR investors are betting against MNPR

MNPR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -13.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.62
Earnings momentum +24.7% Quarterly EPS growth
Quarterly change +24.7%

Valuation

P/E ratio N/A
Enterprise value $485.8M
Beta 1.66

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$134.3M
Debt$108.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $603.4M

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $439.26 -1.79%
MRNA Moderna, Inc. $200.10 -1.25%
RVMD Revolution Medicines, Inc. $186.99 -0.37%
ROIV Roivant Sciences Ltd. $36.49 -2.56%
BNTX BioNTech SE Sponsored ADR $88.12 -1.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.